Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dimethyl fumarate vs fingolimod following different pretreatments: A retrospective study.
Diem L, Daponte A, Findling O, Miclea A, Briner M, Salmen A, Gold R, Kilidireas C, Chan A, Evangelopoulos ME, Hoepner R. Diem L, et al. Among authors: evangelopoulos me. Neurol Neuroimmunol Neuroinflamm. 2020 Jan 14;7(2):e660. doi: 10.1212/NXI.0000000000000660. Print 2020 Mar. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 31937596 Free PMC article.
Different lymphocyte counts of multiple sclerosis patients treated with ofatumumab and ocrelizumab: A retrospective observational study.
Friedli C, Krajnc N, Hammer HN, Marti S, Zrzavy T, Evangelopoulos ME, Kapsali I, Rommer P, Berger T, Chan A, Bsteh G, Hoepner R. Friedli C, et al. Among authors: evangelopoulos me. J Cent Nerv Syst Dis. 2024 May 5;16:11795735241249644. doi: 10.1177/11795735241249644. eCollection 2024. J Cent Nerv Syst Dis. 2024. PMID: 38711956 Free PMC article.
Association of B-cell activating factor gene variants with serum anti-JCV antibody positivity in male patients with multiple sclerosis under natalizumab treatment: Implications for progressive multifocal leukoencephalopathy risk stratification.
Skarlis C, Papadopoulos V, Raftopoulou S, Mavragani CP, Evangelopoulos ME. Skarlis C, et al. Among authors: evangelopoulos me. J Neurol Sci. 2024 May 12;461:123046. doi: 10.1016/j.jns.2024.123046. Online ahead of print. J Neurol Sci. 2024. PMID: 38761670
How Early Is Early Multiple Sclerosis?
Stavropoulou De Lorenzo S, Bakirtzis C, Konstantinidou N, Kesidou E, Parissis D, Evangelopoulos ME, Elsayed D, Hamdy E, Said S, Grigoriadis N. Stavropoulou De Lorenzo S, et al. Among authors: evangelopoulos me. J Clin Med. 2023 Dec 29;13(1):214. doi: 10.3390/jcm13010214. J Clin Med. 2023. PMID: 38202221 Free PMC article. Review.
Multiple faces of multiple sclerosis in the era of highly efficient treatment modalities: Lymphopenia and switching treatment options challenges daily practice.
Vakrakou AG, Brinia ME, Alexaki A, Koumasopoulos E, Stathopoulos P, Evangelopoulos ME, Stefanis L, Stadelmann-Nessler C, Kilidireas C. Vakrakou AG, et al. Among authors: evangelopoulos me. Int Immunopharmacol. 2023 Dec;125(Pt B):111192. doi: 10.1016/j.intimp.2023.111192. Epub 2023 Nov 9. Int Immunopharmacol. 2023. PMID: 37951198 Review.
91 results